cetirizine has been researched along with Dermatitis, Atopic in 55 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to establish whether the use of cetirizine compared with placebo for 18 months in infants with atopic dermatitis suppressed or truly delayed the onset of asthma, even after cessation of therapy." | 9.09 | A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. ( Warner, JO, 2001) |
| "While histamine is the crucial mediator of pruritus in type 1 allergic reactions, its role in atopic dermatitis (AD) is unclear." | 7.70 | Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. ( Heyer, G; Lischetzki, G; McGlone, F; Rukwied, R; Schmelz, M, 2000) |
| "Cetirizine has several antiallergic properties that suggest a potential effect on the development of airway inflammation and asthma in infants with atopic dermatitis." | 6.69 | Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. ( , 1998) |
| "Our objective was to study the effect of long-term treatment with the H(1)-receptor antagonist cetirizine in the prevention of urticaria in young children with atopic dermatitis." | 5.09 | Prevention of acute urticaria in young children with atopic dermatitis. ( Simons, FE, 2001) |
| "We sought to establish whether the use of cetirizine compared with placebo for 18 months in infants with atopic dermatitis suppressed or truly delayed the onset of asthma, even after cessation of therapy." | 5.09 | A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. ( Warner, JO, 2001) |
| "Here we studied the development of erythema after histamine iontophoresis in 12 AE patients and 12 healthy volunteers by means of a RGB-camera for recording true colour images." | 5.08 | Flare responses of atopic eczema patients analysed with true colour images. ( Forster, C; Handwerker, HO; Heyer, G; Nischik, M; Rukwied, R, 1997) |
| "While histamine is the crucial mediator of pruritus in type 1 allergic reactions, its role in atopic dermatitis (AD) is unclear." | 3.70 | Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study. ( Heyer, G; Lischetzki, G; McGlone, F; Rukwied, R; Schmelz, M, 2000) |
| "Atopic dermatitis is a common skin disease encountered in dogs." | 2.80 | Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis. ( Hagihara, A; Higuchi, Y; Kumagai, T; Nagata, M; Ohshima-Terada, Y, 2015) |
| " Safety was assessed by: reporting of adverse events, numbers of children discontinuing the study because of adverse events, height and body mass measurements, assessment of developmental milestones, and hematology and biochemistry tests." | 2.73 | Safety of levocetirizine treatment in young atopic children: An 18-month study. ( Simons, FE, 2007) |
| "Levocetirizine PK were not influenced by eosinophilia, sensitization to allergens, allergic disease, gastroenteritis/diarrhea, or concomitant ingestion of other medications." | 2.71 | Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective. ( Simons, FE, 2005) |
| " In this study we analyzed the effects of the long-term use of cetirizine on the severity, natural history, and treatment of AD." | 2.70 | Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months. ( Diepgen, TL, 2002) |
| " In the first group, only prednicarbat cream was applied to affected places twice a day for a maximum of 10 days, while in the other group also cetirizin was administered once a day in a dosage according to the patient's age." | 2.70 | [Prednicarbate and cetirizin dihydrochloride in the treatment of atopic eczema in the acute phase in children]. ( Bartosíková, L; Dzúrová, J; Frána, L; Frána, P; Kollár, P; Kotolová, H; Necas, J; Petrzelková, J, 2001) |
| "Cetirizine has several antiallergic properties that suggest a potential effect on the development of airway inflammation and asthma in infants with atopic dermatitis." | 2.69 | Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. ( , 1998) |
| "In contrast, controls reported a burning pain after the injection of ACh, whereas AE patients felt predominantly pruritus." | 2.69 | Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. ( Heyer, G; Rukwied, R, 1999) |
| "Our objective was to test the hypothesis that cetirizine would be as safe as placebo for long-term use in this population." | 2.69 | Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. ( Simons, FE, 1999) |
| "Pyrilamine (mepyramine) was not inhibitory in equimolar concentrations." | 2.68 | Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes. ( Deleuran, B; Jinquan, T; Reimert, CM; Simonsen, C; Thestrup-Pedersen, K; Zachariae, C, 1995) |
| "Cetirizine hydrochloride is an orally-active and selective histamine (H(1))-receptor antagonist." | 2.42 | Review of cetirizine hydrochloride for the treatment of allergic disorders. ( Dinakar, C; Portnoy, JM, 2004) |
| "Cetirizine is a safe second generation antihistamine." | 2.40 | Use of cetirizine in dermatologic disorders. ( Henz, BM; Zuberbier, T, 1999) |
| "Cetirizine is a piperazine-derived second-generation antihistaminic drug recommended for treatment of pruritus associated with atopic dermatitis." | 1.39 | Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. ( Goindi, S; Kaur, A; Kumar, G; Kumar, N, 2013) |
| "Cetirizine and placebo were administered orally as individual agents to 23 dogs with atopic dermatitis." | 1.32 | Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: a single-blinded, placebo-controlled study. ( Cobb, SM; Cook, CP; Kirker, JE; Miller, WH; Scott, DW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (34.55) | 18.2507 |
| 2000's | 25 (45.45) | 29.6817 |
| 2010's | 10 (18.18) | 24.3611 |
| 2020's | 1 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Su, Z | 1 |
| Kang, Y | 1 |
| Pal, RR | 1 |
| Parashar, P | 1 |
| Singh, I | 1 |
| Saraf, SA | 1 |
| Goindi, S | 3 |
| Kumar, G | 2 |
| Kumar, N | 1 |
| Kaur, A | 3 |
| Wildermuth, K | 1 |
| Zabel, S | 1 |
| Rosychuk, RA | 1 |
| Dhatt, B | 1 |
| Ohshima-Terada, Y | 1 |
| Higuchi, Y | 1 |
| Kumagai, T | 1 |
| Hagihara, A | 1 |
| Nagata, M | 1 |
| Hsiao, YH | 1 |
| Chen, C | 1 |
| Willemse, T | 1 |
| Izumi, N | 1 |
| Mizuguchi, H | 1 |
| Umehara, H | 1 |
| Ogino, S | 1 |
| Fukui, H | 1 |
| Zitnik, SE | 2 |
| Rüschendorf, F | 1 |
| Müller, S | 2 |
| Sengler, C | 2 |
| Lee, YA | 2 |
| Griffioen, RW | 2 |
| Meglio, P | 2 |
| Wahn, U | 2 |
| Witt, H | 1 |
| Nickel, R | 2 |
| Marenholz, I | 1 |
| Bäumer, W | 1 |
| Stahl, J | 1 |
| Sander, K | 1 |
| Petersen, LJ | 1 |
| Paps, J | 1 |
| Stark, H | 1 |
| Kietzmann, M | 1 |
| Olivry, T | 1 |
| Temizel, EM | 1 |
| Cihan, H | 1 |
| Akhtardanesh, B | 1 |
| Aytug, N | 1 |
| Pfab, F | 1 |
| Kirchner, MT | 1 |
| Huss-Marp, J | 1 |
| Schuster, T | 1 |
| Schalock, PC | 1 |
| Fuqin, J | 1 |
| Athanasiadis, GI | 1 |
| Behrendt, H | 1 |
| Ring, J | 1 |
| Darsow, U | 1 |
| Napadow, V | 1 |
| Stevenson, J | 1 |
| Cornah, D | 1 |
| Evrard, P | 1 |
| Vanderheyden, V | 1 |
| Billard, C | 1 |
| Bax, M | 1 |
| Van Hout, A | 1 |
| Diepgen, TL | 1 |
| Hrachovec, J | 1 |
| Portnoy, JM | 1 |
| Dinakar, C | 1 |
| Cook, CP | 1 |
| Scott, DW | 1 |
| Miller, WH | 1 |
| Kirker, JE | 1 |
| Cobb, SM | 1 |
| Menzies-Gow, A | 1 |
| Ying, S | 1 |
| Phipps, S | 1 |
| Kay, AB | 1 |
| Takahashi, H | 1 |
| Ishida-Yamamoto, A | 1 |
| Iizuka, H | 1 |
| Simons, FE | 4 |
| Guzik, TJ | 1 |
| Bzowska, M | 1 |
| Kasprowicz, A | 1 |
| Czerniawska-Mysik, G | 1 |
| Wójcik, K | 1 |
| Szmyd, D | 1 |
| Adamek-Guzik, T | 1 |
| Pryjma, J | 1 |
| Izu, K | 1 |
| Tokura, Y | 1 |
| Jinquan, T | 1 |
| Reimert, CM | 1 |
| Deleuran, B | 1 |
| Zachariae, C | 1 |
| Simonsen, C | 1 |
| Thestrup-Pedersen, K | 1 |
| La Rosa, M | 1 |
| Ranno, C | 1 |
| Musarra, I | 1 |
| Guglielmo, F | 1 |
| Corrias, A | 1 |
| Bellanti, JA | 1 |
| Goldsmith, P | 1 |
| Dowd, PM | 1 |
| Hannuksela, M | 1 |
| Kalimo, K | 1 |
| Lammintausta, K | 1 |
| Mattila, T | 1 |
| Turjanmaa, K | 1 |
| Varjonen, E | 1 |
| Coulie, PJ | 1 |
| García, G | 1 |
| DeMora, F | 1 |
| Ferrer, L | 1 |
| Puigdemont, A | 1 |
| Atkins, PC | 1 |
| Zweiman, B | 1 |
| Moskovitz, A | 1 |
| von Allmen, C | 1 |
| Ciliberti, M | 1 |
| Rukwied, R | 3 |
| Nischik, M | 1 |
| Forster, C | 1 |
| Heyer, G | 3 |
| Handwerker, HO | 1 |
| Businco, L | 1 |
| Warner, JO | 2 |
| Lippert, U | 1 |
| Hoer, A | 1 |
| Möller, A | 1 |
| Ramboer, I | 1 |
| Cremer, B | 1 |
| Henz, BM | 2 |
| Zuberbier, T | 1 |
| Phillips, RL | 1 |
| Koenig, CJ | 1 |
| Lischetzki, G | 1 |
| McGlone, F | 1 |
| Schmelz, M | 1 |
| de Longueville, M | 1 |
| Furue, M | 1 |
| Terao, H | 1 |
| Koga, T | 1 |
| Boone, M | 1 |
| Lespagnard, L | 1 |
| Renard, N | 1 |
| Song, M | 1 |
| Rihoux, JP | 1 |
| Bartosíková, L | 1 |
| Frána, L | 1 |
| Necas, J | 1 |
| Frána, P | 1 |
| Dzúrová, J | 1 |
| Petrzelková, J | 1 |
| Kollár, P | 1 |
| Kotolová, H | 1 |
| Purohit, A | 1 |
| Duvernelle, C | 1 |
| Melac, M | 1 |
| Pauli, G | 1 |
| Frossard, N | 1 |
| Watanabe, M | 1 |
| Kohge, N | 1 |
| Kaji, T | 1 |
| De Vos, C | 2 |
| Michel, L | 1 |
| Dubertret, L | 1 |
| Massey, WA | 1 |
| Lichtenstein, LM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Management of Pruritus With Xyzal in Atopic Dermatitis in a Randomized, Double-Blind, Placebo Controlled Study[NCT00884325] | Phase 4 | 40 participants (Actual) | Interventional | 2009-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Consented subjects who met inclusion/exclusion criteria were asked to complete a DLQI (Dermatology Life Quality Index)at Baseline, Week 2 and Week 4. The DLQI is a 10 item questionnaire broken down into 6 domains; symptoms and feelings, daily activities, leisure, work and school, personal relationships and treatment with a total score ranging from 0-30 (no effect on subject's life for 0, extremely large effect on subject's life for 30) (NCT00884325)
Timeframe: Baseline - Week 2 - Week 4
| Intervention | units on a scale (Median) | ||
|---|---|---|---|
| DLQI - Baseline | DLQI - Week 2 | DLQI - Week 4 | |
| Subjects Receiving Placebo | 8.00 | 5.5 | 4.00 |
| Subjects Receiving Xyzal | 7.5 | 3.5 | 2.00 |
Consented subjects who met inclusion/exclusion criteria were assigned either 5mg levocetirizine dihydrochloride (Xyzal) or placebo to be taken daily each evening for 28 days. Subjects were asked to complete a Visual Analog Scale to measure itch at Baseline, Week 2 and Week 4. The scale is an eleven point scale ranging from 0-10 with 0 indicating no itch to 10 indicating itch that frequently interferes with daily activities. (NCT00884325)
Timeframe: Baseline - Week 2-Week 4
| Intervention | units on a scale (Median) | ||
|---|---|---|---|
| Baseline | Week 2 | Week 4 | |
| Subjects Receiving Placebo | 7.5 | 5.9 | 6.4 |
| Subjects Receiving Xyzal | 7.8 | 6.10 | 4.15 |
7 reviews available for cetirizine and Dermatitis, Atopic
| Article | Year |
|---|---|
Review of cetirizine hydrochloride for the treatment of allergic disorders.
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Clinical Trials as Topic; Dermatitis, Atopic; Histamine H1 | 2004 |
The new H1 antihistamines. Treatment of urticaria and other clinical problems.
Topics: Astemizole; Cetirizine; Dermatitis, Atopic; Histamine H1 Antagonists; Humans; Loratadine; Terfenadin | 1993 |
Early treatment of the atopic child.
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child, Preschool; Chronic Disease; Clinical Trials as Topi | 1997 |
Use of cetirizine in dermatologic disorders.
Topics: Adolescent; Adult; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Histamine H1 Antagonists; H | 1999 |
What are the candidate groups for pharmacotherapeutic intervention to prevent asthma?
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child; Clinical Trials as Topic; Cromolyn Sodium; Dermatit | 2000 |
Pharmacologic modulation of allergic cutaneous inflammation.
Topics: Allergens; Cetirizine; Dermatitis, Atopic; Eosinophils; Histamine H1 Antagonists; Humans; Hydroxyzin | 1990 |
The effects of antihistamines beyond H1 antagonism in allergic inflammation.
Topics: Benzhydryl Compounds; Cetirizine; Cyproheptadine; Dermatitis, Atopic; Histamine H1 Antagonists; Hist | 1990 |
31 trials available for cetirizine and Dermatitis, Atopic
| Article | Year |
|---|---|
The efficacy of cetirizine hydrochloride on the pruritus of cats with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover study.
Topics: Animals; Anti-Allergic Agents; Cat Diseases; Cats; Cetirizine; Cross-Over Studies; Dermatitis, Atopi | 2013 |
Complementary effect of oral administration of Lactobacillus paracasei K71 on canine atopic dermatitis.
Topics: Animals; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Meth | 2015 |
Effects of cetirizine in dogs with chronic atopic dermatitis: a randomized, double blind, placebo-controlled trial.
Topics: Animals; Cetirizine; Chronic Disease; Dermatitis, Atopic; Dog Diseases; Dogs; Double-Blind Method; F | 2016 |
IL13 variants are associated with total serum IgE and early sensitization to food allergens in children with atopic dermatitis.
Topics: Allergens; Anti-Allergic Agents; Asthma; Cetirizine; Child, Preschool; Dermatitis, Atopic; Egg Hyper | 2009 |
Effect of prednisolone and cetirizine on D. farinae and histamine-induced wheal and flare response in healthy dogs.
Topics: Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; Dermatitis, Atopic; Dermatophag | 2011 |
Acupuncture compared with oral antihistamine for type I hypersensitivity itch and skin response in adults with atopic dermatitis: a patient- and examiner-blinded, randomized, placebo-controlled, crossover trial.
Topics: Acupuncture Therapy; Administration, Oral; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Doubl | 2012 |
Long-term evaluation of the impact of the h1-receptor antagonist cetirizine on the behavioral, cognitive, and psychomotor development of very young children with atopic dermatitis.
Topics: Cetirizine; Child Behavior; Child, Preschool; Cognition; Dermatitis, Atopic; Double-Blind Method; Fe | 2002 |
Long-term treatment with cetirizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (the ETAC trial) over 18 months.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Anti-Allergic Agents; Anti-B | 2002 |
Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans.
Topics: Adult; Cell Adhesion; Cell Line; Cetirizine; Chemokine CCL11; Chemokines, CC; Chemotaxis, Leukocyte; | 2004 |
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzoxepins; Double-Blind Method; Femal | 2004 |
Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Topics: Administration, Oral; Cetirizine; Child, Preschool; Dermatitis, Atopic; Histamine H1 Antagonists, No | 2005 |
Safety of levocetirizine treatment in young atopic children: An 18-month study.
Topics: Asthma; Australia; Cetirizine; Dermatitis, Atopic; Double-Blind Method; Europe; Female; Histamine H1 | 2007 |
Cetirizine inhibits the in vitro and ex vivo chemotactic response of T lymphocytes and monocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Cetirizine; Chemotaxis, Leukocyte; Dermatit | 1995 |
Double-blind study of cetirizine in atopic eczema in children.
Topics: Cetirizine; Child; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Immunoglobulin E; Male; | 1994 |
Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults.
Topics: Administration, Topical; Adult; Alanine Transaminase; Cetirizine; Dermatitis, Atopic; Dose-Response | 1993 |
Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: effects of cetirizine.
Topics: Antigens; Cell Adhesion; Cell Movement; Cetirizine; Dermatitis, Atopic; Diffusion Chambers, Culture; | 1997 |
Flare responses of atopic eczema patients analysed with true colour images.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; Erythema; Female; Hi | 1997 |
Early treatment of the atopic child: first results of the clinical trial.
Topics: Animals; Cetirizine; Dermatitis, Atopic; Double-Blind Method; Histamine H1 Antagonists; Humans; Immu | 1997 |
Determinants of total and specific IgE in infants with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.
Topics: Allergens; Animals; Anti-Allergic Agents; Antibody Specificity; Biomarkers; Canada; Cats; Cattle; Ce | 1997 |
Role of antigen-induced cytokine release in atopic pruritus.
Topics: Adolescent; Adult; Allergens; Animals; Anti-Allergic Agents; Antigens; Cetirizine; Cross-Over Studie | 1998 |
Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
Topics: Allergens; Animals; Anti-Allergic Agents; Asthma; Cats; Cetirizine; Child, Preschool; Dermatitis, At | 1998 |
Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients.
Topics: Acetylcholine; Adult; Cetirizine; Cholinergic Agents; Cross-Over Studies; Dermatitis, Atopic; Double | 1999 |
Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.
Topics: Cetirizine; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Electrocardiography; Eosinoph | 1999 |
Effects of cetirizine and epinastine on the skin response to histamine iontophoresis.
Topics: Administration, Oral; Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzazepines; Dou | 2001 |
Adhesion molecule profiles in atopic dermatitis vs. allergic contact dermatitis: pharmacological modulation by cetirizine.
Topics: Adult; Anti-Allergic Agents; Biopsy; Cetirizine; Cross-Over Studies; Dermatitis, Allergic Contact; D | 2000 |
[Prednicarbate and cetirizin dihydrochloride in the treatment of atopic eczema in the acute phase in children].
Topics: Acute Disease; Administration, Topical; Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; | 2001 |
Prevention of acute urticaria in young children with atopic dermatitis.
Topics: Acute Disease; Cetirizine; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Histamine H1 A | 2001 |
Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Topics: Adolescent; Adult; Anti-Allergic Agents; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Double- | 2001 |
A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up.
Topics: Adolescent; Adult; Anti-Allergic Agents; Asthma; Cetirizine; Child; Dermatitis, Atopic; Double-Blind | 2001 |
Cetirizine effects on the cutaneous allergic reaction in humans.
Topics: Adult; Allergens; Cetirizine; Dermatitis, Atopic; Double-Blind Method; Female; Histamine; Histamine | 1990 |
The effects of antihistamines beyond H1 antagonism in allergic inflammation.
Topics: Benzhydryl Compounds; Cetirizine; Cyproheptadine; Dermatitis, Atopic; Histamine H1 Antagonists; Hist | 1990 |
18 other studies available for cetirizine and Dermatitis, Atopic
| Article | Year |
|---|---|
Influences of Bifid Triple Viable Capsules Plus Cetirizine on Gut Microbiota and Immune Function in Children with Eczema.
Topics: Cetirizine; Child; Child, Preschool; Dermatitis, Atopic; Eczema; Escherichia coli; Gastrointestinal | 2022 |
Tamanu oil potentiated novel sericin emulgel of levocetirizine: repurposing for topical delivery against DNCB-induced atopic dermatitis, QbD based development and
Topics: Animals; Bombyx; Calophyllum; Cetirizine; Chlorocebus aethiops; Dermatitis, Atopic; Dinitrochloroben | 2019 |
Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Cetirizine; Chemistry, Pharmaceutical; Derma | 2013 |
Novel flexible vesicles based topical formulation of levocetirizine: in vivo evaluation using oxazolone-induced atopic dermatitis in murine model.
Topics: Administration, Cutaneous; Animals; Cetirizine; Chemistry, Pharmaceutical; Dermatitis, Atopic; Elast | 2014 |
Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies.
Topics: Administration, Topical; Animals; Cetirizine; Dermatitis, Atopic; Drug Delivery Systems; Female; His | 2014 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniram | 2008 |
Association of Filaggrin loss-of-function-mutations with atopic dermatitis and asthma in the Early Treatment of the Atopic Child (ETAC) population.
Topics: Alleles; Allergens; Asthma; Cetirizine; Dermatitis, Atopic; Double-Blind Method; Filaggrin Proteins; | 2009 |
Lack of preventing effect of systemically and topically administered histamine H(1) or H(4) receptor antagonists in a dog model of acute atopic dermatitis.
Topics: Aging; Animals; Antigens, Dermatophagoides; Cetirizine; Dermatitis, Atopic; Dermatophagoides farinae | 2011 |
Publication bias with cetirizine in atopic dermatitis: safe but ineffective?
Topics: Cetirizine; Child; Dermatitis, Atopic; Histamine H1 Antagonists, Non-Sedating; Humans; Publication B | 2002 |
Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: a single-blinded, placebo-controlled study.
Topics: Administration, Oral; Animals; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dog Diseases; Dog | 2004 |
Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters.
Topics: Administration, Topical; Adult; Anti-Allergic Agents; CD4-CD8 Ratio; Cetirizine; Dermatitis, Atopic; | 2005 |
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; E-Select | 2005 |
Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
Topics: Animals; Calcimycin; Cell Survival; Cetirizine; Concanavalin A; Dermatitis, Atopic; Dog Diseases; Do | 1997 |
[Allergic reactions of skin and mucous membranes. New findings about etiology, pathology and therapy].
Topics: Cetirizine; Dermatitis; Dermatitis, Atopic; Eosinophils; Granulocytes; Histamine Antagonists; Humans | 1994 |
Antihistamines for atopic dermatitis.
Topics: Adolescent; Adult; Aged; Antipruritics; Cetirizine; Child; Clemastine; Dermatitis, Atopic; Double-Bl | 2000 |
Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.
Topics: Adult; Cetirizine; Dermatitis, Atopic; Female; Histamine; Histamine H1 Antagonists; Humans; Inflamma | 2000 |
[Atopic dermatitis in children. Prevention can reduce the incidence of asthma].
Topics: Anti-Allergic Agents; Asthma; Cetirizine; Child; Child, Preschool; Clinical Trials as Topic; Dermati | 2000 |
Severe hepatitis in a patient taking cetirizine.
Topics: Adult; Cetirizine; Chemical and Drug Induced Liver Injury; Dermatitis, Atopic; Histamine H1 Antagoni | 2001 |